Latest News about Stories That Matter
Recent news which mentions Stories That Matter
Nelson Peltz's Trian Fund Management Reshaped Portfolio Ahead Of Presidential Election
November 14, 2024
From Benzinga
From Benzinga
Gary Gensler Hints At Ending His Stint As SEC Chair, Defends Crypto Regulation Agenda
November 14, 2024
From Benzinga
Trump Media Insiders Sell More Than $16 Million In DJT Stock
November 14, 2024
From Benzinga
From Benzinga
Could New Legislation Finally Bring Clarity To US Crypto Rules? Industry Expert Weighs In
November 14, 2024
From Benzinga
Snapchat Puts Family On The Map With New Real-Time Locator
November 14, 2024
From Benzinga
From Benzinga
Alibaba Earnings Could Offer Clues On Challenging Climate: Why Bearish Signals Loom Over China Stock
November 14, 2024
From Benzinga
Trump Plans To Erase EV Tax Credit: Tesla Analyst Says It's 'Net Bullish,' Calls Sell-Off 'Wrong Knee-Jerk Reaction'
November 14, 2024
From Benzinga
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape
November 14, 2024
From Benzinga
Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst
November 14, 2024
From Benzinga
Microsoft Azure Reportedly In Lina Khan's Crosshairs As FTC Considers Anticompetitive Allegations
November 14, 2024
From Benzinga
Pennsylvania Introduces Bitcoin Strategic Reserve Act To Invest Up To $700 Million In BTC
November 14, 2024
From Benzinga
GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
November 14, 2024
From Benzinga
What Is Plug Power's Future? Analysts Warn Of Cash Crunch And Slow Hydrogen Market Growth
November 14, 2024
From Benzinga
Disney's Streaming Profits And Park Rebound Lead The Way: Analyst
November 14, 2024
From Benzinga
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
November 14, 2024
From Benzinga
Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug
November 14, 2024
From Benzinga
Campbell Soup Rao's Brand Growth Strong And US Sales Trend Improving, Analyst Upgrades Stock
November 14, 2024
From Benzinga
Applied Materials: Bearish Chart Signals Ahead Of Q4 Earnings – 9% Upside In Sight?
November 14, 2024
From Benzinga
Trump's Red Wave Pushes Emerging Market Stocks To 2-Month Lows: Volatility 'Expected To Remain Elevated'
November 14, 2024
From Benzinga
Trump Rally Fades As Investors Await Powell's Remarks, Bitcoin Drops Below $90,000: What's Driving Markets Thursday?
November 14, 2024
From Benzinga
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
November 14, 2024
From Benzinga
Bitcoin Miner Hut 8 Shares Dip Despite Strong Q3; Analysts Remain Bullish On AI, Crypto Potential
November 14, 2024
From Benzinga
From Benzinga
Inseego's Turnaround Gains Traction: New Products And Partnerships to Fuel Future Growth, Says Analyst
November 14, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
